Trade IXHL stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Incannex Healthcare Inc. (IXHL) is trading at US$3.64, up 1.39% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$42.71M. Over the past 52 weeks, IXHL has traded between US$2.49 and US$20.31. On Syfe you can trade IXHL with $0 commission and add it to your watchlist.
| Previous close | US$3.59 |
|---|---|
| Market cap | US$42.71M |
| 52-week range | US$2.49 – US$20.31 |
| Volume | 91.42K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Incannex Healthcare Inc.
Incannex Healthcare, Inc. is a biotech company, which engages in developing cannabinoid and psychedelic compound medicines. It focuses on the research and development for medicinal cannabis pharmaceutical products and psychedelic medicine therapies for treatment of a range of indications. The company was founded on April 27, 2001 and is headquartered in Norwest, Australia.
Year: 2022
Incannex Healthcare Receives US Patent for IHL-42X in Obstructive Sleep Apnea
Jun 25, 12:26 PM · MT Newswires
Incannex Healthcare Inc. (IXHL) stock is trading at US$3.64, +1.39% from the previous close of US$3.59.
The market cap for Incannex Healthcare Inc. (IXHL) stock is approximately US$42.71M.
The 52-week high for Incannex Healthcare Inc. (IXHL) stock is US$20.31.
The 52-week low for Incannex Healthcare Inc. (IXHL) stock is US$2.49.
Incannex Healthcare Inc. (IXHL) does not currently pay a dividend.
Stay on top of IXHL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
